tebu-bio is a European company specialised in providing innovative reagents and laboratory services in Life Sciences
X

Need an answer now?

Give us a call

Leave a message, we'll get back to you





Get advice about Time Bioscience

Time Bioscience

Time Bioscience - tebu-bio

Time Bioscience manufacture in vitro assay tools focusing on the Wnt/beta-catenin cell signaling pathway for drug discovery. Time Bioscience's focus lays on highly active proteins involved in this pathway like Wnt variants, Wnt signaling inhibitors, and Wnt signaling receptors, as well as reporter cell lines and their control cell lines.
 



Find your Time Bioscience products below or contact your tebu-bio local office.

Split per category

Cells, Media & Fractions

Cell Lines

Proteins & Peptides

Proteins

1 services

46 blog articles

5 webpages

1 Services

46 blog articles


3 novel PD-L1 post-translational modifications identified | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

New Continued use immunotherapy cell line expressing recombinant PD-1 | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

IDO/TDO enzymatic pathway as an additional target for Cancer Drug Discovery | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

New Reporter cell lines for Drug discovery and Immunotherapy checkpoint research | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

10 Human Immune Checkpoint biomarkers quantified simultaneously | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

How to improve your reporter gene assays? | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

drug discovery | tebu-bio's blog - Part 3 Facebook Google+ LinkedIn Twitter YouTube

Versatile method to detect luciferase in reporter cell lines | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Immunotherapy research: How to easily build your own reporter cell line? | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

A focus on ATX-LPA signaling research tools | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

ELISA test to confirm elimination of Host Cell Proteins (HCP) from bioproductions | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

3D cell culture: discover the new VitroGelTM 3D Hydrogel system | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Six new reporter cellular lines for Immune checkpoint drug discovery | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Cell-based assay to discover new immuno-oncology treatments | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

New FcGR2B cell line: Boost your Immunotherapeutic antibody development | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

tebu-bio's blog | Acting and reacting in life sciences and biotechnologies - Part 30 Facebook Google+ LinkedIn Twitter YouTube

drug discovery | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

tebu-bio's blog | Acting and reacting in life sciences and biotechnologies - Part 29 Facebook Google+ LinkedIn Twitter YouTube

drug discovery | tebu-bio's blog - Part 10 Facebook Google+ LinkedIn Twitter YouTube

cancer | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

How to optimise your recombinant protein purification and protein production | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Prevent adapter dimer formation during NGS library prep | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Immunotherapy Screening B7-1 / CD28 and B7-1 / CTLA4 Pathways in Drug Discovery | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Screen for inhibitors of PD-1 signalling with a complete cellular assay system | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Immunotherapy Screening IDO pathway | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Immunotherapy Screening CD137:CD137L pathway | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Immunotherapy Screening CD40:CD40L pathway | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Immunotherapy Screening A focus on PD-1/PD-L1/PD-L2 Pathway in drug discovery | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

IL-17A pathway a key target for immunotherapies | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Cell-based assay to discover new immuno-oncology treatments | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

tebu-bio's blog | Acting and reacting in life sciences and biotechnologies - Part 9 Facebook Google+ LinkedIn Twitter YouTube

immune system | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Array profiling to study PPAR-alpha in progenitor cell | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Histone Deacetylases (HDACs) and Alzheimer | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Where can I find the best PARPs? | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

tebu-bio's blog | Acting and reacting in life sciences and biotechnologies - Part 42 Facebook Google+ LinkedIn Twitter YouTube

Cancer immunotherapy: IDO1 inhibitors reversible or irreversible? | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

tebu-bio's blog | Acting and reacting in life sciences and biotechnologies - Part 32 Facebook Google+ LinkedIn Twitter YouTube

Measure Antibody-Dependent Cell-mediated Cytotoxicity (ADCC) | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Cancer Immunotherapy: Targeting CD73 to inhibit adenosine generation | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

New research tools targeting PCSK9 and LDLR | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Cancer Immunotherapy Investigate the TIGIT/CD226 Pathway | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Find the best epigenetic enzyme substrate for your needs | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

Return of SIRT1 deacetylase Why is SIRT1 so attractive in Drug discovery and Stem cell research? | tebu-bio's blog Facebook Google+ LinkedIn Twitter YouTube

tebu-bio's blog | Acting and reacting in life sciences and biotechnologies - Part 7 Facebook Google+ LinkedIn Twitter YouTube

tebu-bio's blog | Acting and reacting in life sciences and biotechnologies - Part 41 Facebook Google+ LinkedIn Twitter YouTube

5 Webpages